YU160990A - Novi derivati aminopropanola, postupak za njihovo pravljenje i farmaceutski preparati koji sadrže iste - Google Patents

Novi derivati aminopropanola, postupak za njihovo pravljenje i farmaceutski preparati koji sadrže iste

Info

Publication number
YU160990A
YU160990A YU160990A YU160990A YU160990A YU 160990 A YU160990 A YU 160990A YU 160990 A YU160990 A YU 160990A YU 160990 A YU160990 A YU 160990A YU 160990 A YU160990 A YU 160990A
Authority
YU
Yugoslavia
Prior art keywords
group
hydrogen atom
optionally substituted
independently
phenyl
Prior art date
Application number
YU160990A
Other languages
English (en)
Other versions
YU48372B (sh
Inventor
Z. Budai
T. Mezei
L. Petocz
M. Szeczey
M. Fekete
V. Hoffmann
K. Reiter
E. Szirt
G. Zsila
G. Gigler
L. Kapolnai
Original Assignee
Egis Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar filed Critical Egis Gyogyszergyar
Publication of YU160990A publication Critical patent/YU160990A/sh
Publication of YU48372B publication Critical patent/YU48372B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/20Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups being part of rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/50Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered

Abstract

NOVI DERIVATI AMINOPROPANOLA, POSTUPAK ZA NJIHOVO PRAVLJENJE I FARMACEUTSKI PREPARATI KOJI SADRŽE ISTE. Pronalazak se odnosi na nove racemske ili optički aktivne derivate formule I: u kojoj su: R i R1 nezavisno vodonikov atom, halogenski atom, niži alkoksi, ili zajednički pretstavljaju metilendioksi grupu, R2 i R3 zajednički pretstavljaju hemijsku vezu ili nezavisno pretstavljaju hemijsku vezu ili nezavisno pretstavljaju vodonikov atom, R4 i R5 su nezavisno vodonikov atom, C3-C7 cikloalkil grupa ili prava ili račvasta, zasićena ili nezasićena C1-12alkil grupa koja je opciono supstituisana sa jednom ili više dialkilaminoalkil, dimetoksifenil ili fenil grupa, ili R4 i R5 zajedno su susednim atomom azota formiraju 4 do 7-člani prsten koji opciono obuhvata atom kiseonika, sumpora ili dalji atom azota, pri čemu je prsten opciono supstituisan sa fenil, benzil ili C1-3 alkil grupom i pomenuti supstituent mogu nositi hidroksi grupu, jednu ili dve metoksi grupe, halogenske atome ili trifluorometil grupe, ili R4 i R5 zajedno sa susednim atomom azota formiraju piperidinski prsten koji je opciono supstituisan sa fenil ili benzil grupom i, ako se želi, obuhvata dvogubu vezu, R6 pretstavlja vodonikov atom ili benzoil grupu, i n pretstavlja ceo broj od 3 do 6, njihove adicione soli sa kiselinama i kvaternerni amonijum derivati, Dalje se pronalazak odnosi na postupke za pravljenje ovih jedinjenja. Jedinjenja iz pronalaska ispoljavaju efekte za poboljšanje kontrole kardijačne cirkulacije i/ili smirivanja centralnog nervnog sistema i/ili poboljšavanje nepravilnosti digestivnog sistema.
YU160990A 1989-08-25 1990-08-23 Novi derivati aminopropanola i postupak za njihovo pravljenje YU48372B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894401A HU212415B (en) 1989-08-25 1989-08-25 Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components

Publications (2)

Publication Number Publication Date
YU160990A true YU160990A (sh) 1992-12-21
YU48372B YU48372B (sh) 1998-07-10

Family

ID=10967860

Family Applications (1)

Application Number Title Priority Date Filing Date
YU160990A YU48372B (sh) 1989-08-25 1990-08-23 Novi derivati aminopropanola i postupak za njihovo pravljenje

Country Status (23)

Country Link
US (1) US5130487A (sh)
JP (1) JPH03169841A (sh)
KR (1) KR910004547A (sh)
AT (1) AT399504B (sh)
BE (1) BE1004530A3 (sh)
CA (1) CA2023957A1 (sh)
CH (1) CH681369A5 (sh)
DD (1) DD297402A5 (sh)
DE (1) DE4027052A1 (sh)
DK (1) DK203290A (sh)
ES (1) ES2021261A6 (sh)
FI (1) FI904191A0 (sh)
FR (1) FR2651227B1 (sh)
GB (1) GB2235198B (sh)
GR (1) GR1000740B (sh)
HU (1) HU212415B (sh)
IT (1) IT1243203B (sh)
NL (1) NL9001865A (sh)
PL (1) PL163028B1 (sh)
RU (1) RU2066310C1 (sh)
SE (1) SE9002727L (sh)
YU (1) YU48372B (sh)
ZA (1) ZA906744B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212262B (en) * 1992-10-30 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process to prepare benz /e/ indene derivs. and the pharmaceutical compns. contg. them
HUT67314A (en) * 1993-04-09 1995-03-28 Egyt Gyogyszervegyeszeti Gyar Process for prepg. new trisubstituted cykloalkane deriv.s and pharmaceutical compn.s contg. them
HU213421B (en) * 1993-04-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar New basic ethers, pharmaceutical compns. containing the said compds. and process for prepg. them
HU213472B (en) * 1993-07-20 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process to preparare pharmaceutical compns. with gastroprotective and anti helicobacter pylori activity
US5597822A (en) * 1993-07-20 1997-01-28 Egis Pharmaceutical Pharmaceutical compositions for the prevention and/or treatment a gastrointestinal diseases
DE19722848A1 (de) * 1997-05-23 1998-11-26 Schering Ag Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten
BR0306811A (pt) * 2002-01-11 2004-10-26 Sankyo Co Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
AT339276B (de) * 1976-01-27 1977-10-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur herstellung von basischen cycloalkanonoximathern und deren saureadditionssalzen
DK149043C (da) * 1976-01-27 1986-05-26 Egyt Gyogyszervegyeszeti Gyar Analogifremgangsmaade til fremstilling af 2-benzal- eller 2-benzyl-1-(aminoalkoxyimino)-cykloalkaner eller salte eller kvaternaere ammoniumderivater deraf
DE2658938A1 (de) * 1976-12-24 1978-07-06 Hoechst Ag Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4652586A (en) * 1980-11-07 1987-03-24 The General Hospital Corporation Selective beta-2 adrenergic antagonists for the treatment of glaucoma
FR2521856A1 (fr) * 1982-02-19 1983-08-26 Pos Lab Medicament ophtalmique pour le traitement des glaucomes, a base d'ethers-oxydes ou d'ether-oximes de derives alcoylamines
HU189227B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing basic oxime-ethers
HU189226B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing basic oxime-ethers
HU197205B (en) * 1984-07-10 1989-03-28 Egyt Gyogyszervegyeszeti Gyar Process for production of medical compositions against angine
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers

Also Published As

Publication number Publication date
HUT58282A (en) 1992-02-28
US5130487A (en) 1992-07-14
FR2651227A1 (fr) 1991-03-01
ATA174290A (de) 1994-10-15
SE9002727L (sv) 1991-02-26
DK203290A (da) 1991-02-26
PL286613A1 (en) 1991-05-06
CH681369A5 (sh) 1993-03-15
BE1004530A3 (fr) 1992-12-08
IT9021305A1 (it) 1992-02-24
GB2235198A (en) 1991-02-27
SE9002727D0 (sv) 1990-08-24
DE4027052A1 (de) 1991-03-07
GR900100627A (en) 1991-12-30
GR1000740B (el) 1992-12-30
DK203290D0 (da) 1990-08-24
NL9001865A (nl) 1991-03-18
AT399504B (de) 1995-05-26
YU48372B (sh) 1998-07-10
HU212415B (en) 1996-06-28
KR910004547A (ko) 1991-03-28
FI904191A0 (fi) 1990-08-24
CA2023957A1 (en) 1991-02-26
GB9018583D0 (en) 1990-10-10
ZA906744B (en) 1991-06-26
FR2651227B1 (fr) 1992-07-31
GB2235198B (en) 1993-06-02
RU2066310C1 (ru) 1996-09-10
IT1243203B (it) 1994-05-24
ES2021261A6 (es) 1991-10-16
PL163028B1 (pl) 1994-02-28
JPH03169841A (ja) 1991-07-23
DE4027052C2 (sh) 1993-09-09
IT9021305A0 (it) 1990-08-24
DD297402A5 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
FR2701026B1 (fr) Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
OA09482A (fr) "Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
HRP20021023B1 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
YU22996A (sh) Novi derivati arilglicinamida postupci za njihovo pripremanje i farmaceutski preparati koji sadrže ova jedinjenja
BR0113078A (pt) Uso de um composto, composto, processo para a preparação do mesmo, composição farmacêutica, e, método para produzir um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente
FR2695387B1 (fr) Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
YU160990A (sh) Novi derivati aminopropanola, postupak za njihovo pravljenje i farmaceutski preparati koji sadrže iste
SE8605504D0 (sv) Novel chroman derivatives
KR890001957A (ko) N-아미노부틸-n-페닐아릴아미드 유도체, 그의 제법 및 치료에의 응용
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
DZ1417A1 (fr) Composés nouveaux 8-substitués-2-aminotétraline.
YU109292A (sr) 3(2h)-piridazinon derivati i postupak za njihovo dobijanje
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DK160486C (da) N-(4-amino-2,2-diphenyl-butyl)- eller n-(3-amino-2,2-diphenyl-propyl) urinstofforbindelser, fremgangsmaade til fremstilling af disse, samt en farmaceutisk komposition
FR2536075B1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE69130266T2 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
DE60011241D1 (de) Neue diazol-derivate und ihre verwendung als serotonergische wirkstoffe
FI894068A (fi) Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel.
NO164024C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner.
YU58093A (sh) 1,3,4-benzotriazepin-5(4h)-on derivati i postupak za njihovo dobijanje
BE1002518A4 (fr) Nouveaux derives de quinoleinium et d'isoquinoleinium et procede pour leur preparation.
FR2677647B1 (fr) Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
TH9320EX (th) อนุพันธ์อะมิโนโพรพานอลชนิดใหม่กรรมวิธีสำหรับการเตรียมและสารผสมทางเภสัชกรรมชนิดต่าง ๆ ที่ประกอบไปด้วยสารชนิดเดียวกัน
TW226996B (en) Novel isatin and oxindole derivatives which are acetylcholinesterase inhibitors, a process and intermediates for preparing said derivatives and a pharmaceutical composition thereof